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: Gadolinium-enhanced sagittal T1-weighted image shows an enhancing space-occupying mass in the convexity of the left temporal lobe found in the sigmoid and a sigmoidectomy, along with a Whipple procedure, were performed. Preoperatively, he underwent diffusor tensor imaging measurements. The clear cell morphology prompted initial differential diagnostic considerations of various cell types of metastatic carcinoma. However, the positive melanocytic immunohistochemical markers, as well as the preexistent skin lesion, established our final diagnosis.
BCM features are a rare histologic variant seen in benign melanocytic nevi and malignant melanomas and are characterized by the presence of a large amount of cytoplasm with vacuoles. [4] Although it is generally believed that BCM cells represent a degenerative change, the immunohistochemical and electron microscopic findings suggest that they are most likely metabolically active melanocytic cells and contain round, stage I melanosomes without melanin. [5] Its immunohistochemical positivity for melanocytic markers such as S100, Melan-A, and HMB-45 helps in differentiating BCM from its mimickers. [1] The differential diagnosis for nonneoplastic clear cells includes lesions containing foamy histiocytes, xanthoma cells, adipocytes, and mucopolysaccharidoses. Nonmelanocytic malignant clear cell tumors include atypical fibroxanthoma, liposarcoma, chondrosarcoma, clear cell sarcoma of soft parts, perivascular epithelioid cell tumors (PEComa), myoepithelial carcinoma, squamous cell carcinoma with clear cell change, sebaceous and other cutaneous adnexal carcinomas, such as (malignant) clear [4, 5] Immunohistochemistry is helpful in excluding many of these entities. However, one must keep in mind that some clear cell tumors are immunopositive for melanocytic markers, such as Melan-A+ adrenal cortical carcinomas, HMB-45+ PEComas, and hibernomas with balloon-like S-100+ vacuolated cells. [1, 6] There appears to be no difference in prognosis between BCM and other histologic types of cutaneous malignant melanoma. [4, 5] There have been few reports of metastatic BCM, but we were able to identify only three prior case reports of metastatic BCM specifically to the central nervous system (CNS). [1] [2] [3] BCM has also been reported as a primary lesion of the CNS arising from the leptomeninges. [7] To the best of our knowledge, this is only the fourth reported case of metastatic BCM to the CNS. An additional reason for sharing this interesting case is to demonstrate that BCM can be a challenging diagnosis to make in frozen section and pathology in general. Given the rarity of this entity, it is essential to consider BCM in the large differential diagnosis of clear cell tumors. This sort of cases emphasizes the need for an accurate clinical history and the significance of determining if there is any relevant history of malignancy. [1, 8] 
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